• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Verily Powers Otsuka’s Longitudinal Registry to Advance Mental Health Research

by Fred Pennic 04/08/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, and Verily Life Sciences LLC (Verily), a precision health technology company, have teamed up to launch a groundbreaking research initiative called “My Mental Health Journey.” 

– The longitudinal registry study aims to significantly enhance our understanding of depression and other mental health conditions.

The Power of Real-World Data

My Mental Health Journey will enroll adult participants in the U.S. who are experiencing symptoms of depression. This large-scale observational study will leverage real-world data to provide valuable insights:

  • Understanding Depression’s Progression: By tracking participants’ experiences over time, researchers will gain a deeper understanding of how depression evolves.
  • Diversity and Inclusion: The study design prioritizes enrolling a diverse population, ensuring research reflects the true spectrum of depression.

Participant Engagement through Technology

Participation in My Mental Health Journey is designed to be convenient and informative:

  • Self-Guided Assessments: Participants will periodically complete online surveys about their depression journey.
  • Digital Data Collection: Securely shared digital data will contribute valuable real-world information to the study.
  • Access to Resources: Participants will receive access to educational resources on depression and related mental health topics.
  • Future Research Opportunities: Participants will have a simplified path to participate in future clinical research studies focused on mental health.

Verily Viewpoint: Powering the Study

Verily will utilize its expertise in precision health technology to manage the study through its Verily Viewpoint platform. This platform offers:

  • End-to-End Solutions: Verily Viewpoint provides a comprehensive suite of tools for participant recruitment, data collection, and analysis.
  • Streamlined User Experience: The platform prioritizes a user-friendly design to ensure a positive experience for participants.
  • Multi-modal Data Collection: The platform gathers various data points to create a holistic picture of participants’ experiences.

Availability

The My Mental Health Journey registry is now enrolling participants across the United States. If you or someone you know is experiencing symptoms of depression and is interested in contributing to this vital research effort

“We are excited to help usher in the age of precision for mental health care by leveraging multimodal data to give a more complete picture of a person’s individual journey through treatment,” said Andrew Trister, MD, PhD, chief medical and scientific officer at Verily. “Our work with Otsuka offers the promise to accelerate the development and delivery of innovative treatments for depression to serve the millions of patients in need of safe, effective, and accessible care.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Behavioral Health, Mental Health, Verily

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |